NEWCELX RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHTue, 30 Jun 2026 19:18:23 +0200https://images.finanzen.net/images/finanzen_net_neu.gifNEWCELX RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netNewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune SuppressionMon, 12 Jan 2026 13:00:00 +0100https://www.finanzen.net/nachricht/aktien/newcelx-announce-positive-results-from-international-collaborative-study-exploring-advanced-biomaterial-approaches-for-stem-cell-derived-islet-delivery-in-type-1-diabetes-without-immune-suppression-15408861

ZURICH, Jan. 12, 2026 /PRNewswire/ -- NewcelX ...

]]>https://www.finanzen.net/nachricht/aktien/newcelx-announce-positive-results-from-international-collaborative-study-exploring-advanced-biomaterial-approaches-for-stem-cell-derived-islet-delivery-in-type-1-diabetes-without-immune-suppression-15408861NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory BoardMon, 05 Jan 2026 13:00:00 +0100https://www.finanzen.net/nachricht/aktien/newcelx-appoints-dr-julien-boisdron-a-swiss-big-pharma-leader-in-diabetes-innovation-to-its-scientific-advisory-board-15391981

ZURICH and NESS ZIONA, Israel, Jan. 5, 2026 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/newcelx-appoints-dr-julien-boisdron-a-swiss-big-pharma-leader-in-diabetes-innovation-to-its-scientific-advisory-board-15391981